Skip to main content

Injectable electrodes may help treat everything from chronic pain to depression

Biomedical Engineering Professor Kip Ludwig explains neuromodulation

A novel drug-free treatment for health conditions ranging from chronic pain to epileptic seizures or depression could be on the horizon — and it involves injectable electrodes.

Recommended Videos
From 3D-printed prostheses to burgers grown in science labs to smarter mobility for the elderly or infirm, tech improves our lives every day in a million ways beyond simply making things more convenient. Tech can have a meaningful impact — that’s why we call it Tech for Change. Here are the companies and people fighting to make a difference.
Tech for Change

The concept builds on the technique of electrically stimulating nerves. This kind of neuromodulation treatment is already in service in today’s hospitals. It works by altering nerve activity through targeted electrical stimulation. While this has been shown to be effective, however, the treatment also poses problems. Specifically, surgically implanted devices can be expensive, require complex procedures to install, and are prone to failing due to the challenge of getting rigid devices to interact with the body’s soft biological tissues.

The new approach — referred to as “injectrodes” by its creators — involves electrodes injected into the body as a liquid. The injectrodes are made from a silicone base, similar to a surgical sealant, infused with small metal particles to make the liquid conductive. Once injected, the material then cures inside the body, establishing a new kind of neural interface system.

Neuronoff, Inc.

“The envisioned patient experience is an outpatient procedure that begins with a local numbing of the intended injection location with an anesthetic agent such as lidocaine,” Manfred Franke, co-founder and CEO of Neuronoff, the company set up to commercialize the technology, told Digital Trends. “Using ultrasound or fluoroscopy to visualize the local anatomy, the physician places the injectrode via needle injection onto, into, or around the anatomical area of interest. This may be a nerve or it may be other tissues that the physician wants to apply energy to, such as electrical stimulation of nerves or currents to ablate certain tissues within the body. Once the injectrode material is placed into the body, it undergoes a transformation from its initial liquid, or moldable, form to a solid form within the body, essentially curing in-vivo. Around a week later, the patient would then return to receive the treatment, using an external signal generator unit to deliver the desired electrical signal to the intended target.”

The approach has already been put through chronic preclinical tests. “Our team is working diligently to get this technology out to patients as quickly as possible,” said Andrew Shoffstall. “The team recently received a $2.2m grant from the HEAL program at the National Institutes of Health. This work will greatly increase our ability to validate the safety and efficacy of the technology before we move into clinical trials.”

A paper describing the work was recently published in the journal Advanced Healthcare Materials.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Cadillac offers first glimpse of upcoming Optiq-V performance EV
cadillac optiq v teaser ev

Cadillac has released the first official teaser images of the 2026 Optiq-V, offering a preview of the brand’s second all-electric model to join the performance-focused V-Series lineup. The images, which highlight subtle styling upgrades, mark the first confirmation of the new variant ahead of its full reveal later this year.
The Optiq-V builds on the foundation of the standard Optiq, Cadillac’s compact electric SUV introduced for the 2025 model year. According to the automaker, this V-Series version will feature a more dynamic driving experience, with enhancements to steering, suspension, and overall agility. While technical details remain limited, Cadillac’s press release emphasizes that the Optiq-V was engineered for “precision” and an “exhilarating” feel behind the wheel.
Reports from CarScoops suggest the Optiq-V could produce up to 515 horsepower through a dual-motor all-wheel-drive system, significantly surpassing the 300 horsepower of the base model. Teaser images reveal a diamond-pattern mesh grille, V-Series badging, and a rear spoiler — all nods to its performance orientation. Photos also hint at additional visual updates, such as redesigned bumpers, 21-inch wheels, and larger brakes.
The base Optiq, reviewed recently by Digital Trends, is positioned as Cadillac’s entry-level EV and shares its underpinnings with the Chevrolet Equinox EV. Despite that connection, the Optiq features premium materials, a curved 33-inch display, Google built-in tech, and standard dual-motor all-wheel drive. While the review noted some drawbacks in steering feel and performance tuning, it praised the vehicle's cabin quality and overall comfort.
The Optiq-V is expected to retain the standard model’s 85-kWh battery and roughly 300-mile range, though final figures have yet to be announced. Cadillac says more details on specs and pricing will be available closer to the model’s official launch.
With the addition of the Optiq-V, Cadillac continues expanding its electric lineup while reinforcing its V-Series as a key part of its identity — now in the EV era.

Read more
Nissan delays price increases until June amid U.S. tariffs
nissan rogue hybrid 2025 2024

Nissan buyers, take note: if you're eyeing a new ride, you might want to make your move before summer. The automaker has announced it won’t raise prices on imported vehicles until at least June 2, giving car shoppers a brief reprieve from the impact of the new 25% U.S. import tariffs.
According to a memo sent to U.S. dealers and reported by Automotive News, Nissan is able to hold prices steady thanks to a stockpile of tariff-free vehicles—enough to last nearly three months. But once that inventory runs dry? Prices are likely heading north. Nissan’s U.S. sales chief Vinay Shahani assured dealers that the company is working to "minimize the impact" of tariffs on customers, but he was also frank: “There will be an impact.”
To soften the blow, Nissan is ramping up production at its U.S. plants in Smyrna, Tennessee, and Canton, Mississippi. Those factories were only running at about half capacity last year, so there’s plenty of room to grow. The Rogue—Nissan’s best-seller—will get a second shift on its assembly line, increasing production by about 60,000 vehicles. Other models like the Pathfinder, Frontier, and Murano will also see higher domestic output.
The goal? Build more cars stateside and dodge the tariff altogether.
Nissan’s move puts it in line with other automakers holding the line on prices—at least for now. Hyundai, Toyota, and Honda have made similar pledges, while rivals like Ford and Stellantis are rolling out temporary discounts to ease the pain.
As Digital Trends noted, Nissan’s decision comes as it rethinks its production and pricing strategy in the face of shifting trade policies and a nervous market. With high-volume imports like the Sentra and Ariya still coming from Mexico and Japan, this pricing grace period might not last long.

Read more
Buick, Audi, and Nissan score top marks in latest IIHS safety ratings
2025 Audi Q6 e-tron front quarter view.

The Insurance Institute for Highway Safety (IIHS) has added four more vehicles to its coveted 2025 Top Safety Pick and Top Safety Pick+ lists. If you appreciate knowing your vehicle is built with safety in mind, this update is worth noting.

Among the standout performers: the Audi Q6 e-tron, Buick Enclave, and Nissan Armada—each earning the institute’s highest honor, the Top Safety Pick+ award. The GMC Acadia also made the grade, picking up a Top Safety Pick award. For Buick and GMC, these honors mark a significant return to form, as neither brand had received IIHS awards in several years. In fact, it’s the first time since 2013 that the Enclave has been recognized.
So, how does IIHS hand out these awards? Picture a battery of tests that simulate real-world crashes—everything from small overlap front impacts to updated side crashes. To make the list, vehicles must ace (i.e., earn a “good” rating in) key crashworthiness tests, show competence in pedestrian crash prevention, and offer headlights that don’t blind oncoming drivers. For the higher-tier Top Safety Pick+, there's an extra hurdle: a “good” rating in the updated moderate front overlap test, which now factors in rear-seat passenger protection.
Improvements to the Enclave and Acadia’s headlights, introduced after January 2025, helped push them over the finish line. Unfortunately, not all models in this testing round were so lucky. The Cadillac Lyriq, Audi Q6 Sportback e-tron, Kia K4, and several Nissan models—including the Kicks, Rogue, and Sentra—fell short. Common issues? Poor headlight performance or incomplete testing.
The IIHS notes that these evaluations are ongoing. Not every vehicle released for 2025 has been fully assessed, and late-year updates can still improve a model’s score. For the full list of safety awards, you can check out the IIHS website.

Read more